A comment on: "Risk of nonarteritic anterior ischemic optic neuropathy in patients prescribed semaglutide".

Autor: Hasanzad M; Personalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran., Patrinos GP; School of Health Sciences, Department of Pharmacy, University of Patras, Patras, Greece.; College of Medicine and Health Sciences, Department of Genetics and Genomics, United Arab Emirates University, Al-Ain, Abu Dhabi, UAE.; Zayed Center for Health Sciences, United Arab Emirates University, Al-Ain, Abu Dhabi, UAE., Aghaei Meybodi HR; Evidence Based Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran., Nikfar S; Personalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran., Larijani B; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Jazyk: angličtina
Zdroj: Journal of diabetes and metabolic disorders [J Diabetes Metab Disord] 2024 Sep 09; Vol. 23 (2), pp. 2411-2414. Date of Electronic Publication: 2024 Sep 09 (Print Publication: 2024).
DOI: 10.1007/s40200-024-01493-5
Abstrakt: Competing Interests: Conflict of interestThere are no conflicts of interest declared by the authors.
Databáze: MEDLINE